HSTOQ (Histogen) Total Operating Expense: $12.07 Mil (TTM As of Sep. 2023)


HSTOQ Histogen Inc HSTOQ
12 GF Score
Price $0.00
View Full Analysis

What is Histogen Total Operating Expense?

Histogen HSTOQ +316.67% 12 Total Operating Expense is $12.07 Mil as of Sep. 2023. GuruFocus rates HSTOQ with a GF Score™ of 12/100.

Histogen's Total Operating Expense for the three months ended in Sep. 2023 was $3.53 Mil. Histogen's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was $12.07 Mil.

Histogen Total Operating Expense Related Terms

Histogen Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Histogen's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Histogen Total Operating Expense Chart

Histogen Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Operating Expense
10.16 12.81 16.16 14.41

Histogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.60 2.97 3.48 2.09 3.53
HSTOQ
12GF Score
Histogen Inc HSTOQ
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Histogen Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $12.07 Mil mean?
Histogen (HSTOQ) has a Total Operating Expense of $12.07 Mil as of Sep. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Histogen and its competitors.
Is Histogen's Total Operating Expense too high?
Histogen's current Total Operating Expense is $12.07 Mil. Overall, Histogen has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Histogen's Total Operating Expense compare to GLMD and BLCM?
Histogen's Total Operating Expense of $12.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Histogen and its competitors. Histogen's current Total Operating Expense is $12.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Histogen stock overvalued right now?
Histogen (HSTOQ) has a current Total Operating Expense of $12.07 Mil. The current Total Operating Expense is $12.07 Mil. Histogen's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Histogen (HSTOQ), the current Total Operating Expense is $12.07 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Histogen Business Description

Address 10655 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
12GF Score

Get the complete analysis for HSTOQ

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price